December 2, 2025: Community Engagement Strategies Boost Rural Enrollment in FM-TIPS Fibromyalgia Trial

FM-TIPS logoNew findings from FM-TIPS show that targeted community engagement methods are highly effective in increasing recruitment and enrollment, particularly among rural participants who are typically underrepresented in clinical research.

The report was published online in the Journal of Clinical and Translational Science.

FM-TIPS, an NIH Collaboratory Trial, is a cluster randomized trial examining whether adding transcutaneous electrical nerve stimulation to routine physical therapy improves outcomes for patients with fibromyalgia receiving care in physical therapy clinics. Recruitment for clinical trials often faces barriers in rural communities, which make up 19% of the US population but experience a significant burden of chronic pain, including fibromyalgia.

To address projected low enrollment rates in certain locations, the FM-TIPS study team implemented specific community engagement strategies partway through the trial for 2 groups: targeted rural clinics and targeted low-enrollment clinics. They compared these groups to a group of untargeted clinics.

The initiative was guided by 2 full-time community engagement coordinators who tailored a multipronged approach for each local community. Strategies included posting individualized flyers in public spaces, conducting physician outreach, and using social media ads and direct mail campaigns. Key to the initiative’s success was establishing strong partnerships with local physical therapy clinics and their staff, who served as trusted community members.

Implementation of these strategies resulted in a significant increase in study inquiries, screening, and enrollment. Average monthly inquiries across all clinics rose from 2 per month to 28, a 760% increase over projected numbers. The most effective strategies for generating inquiries were social media ads and direct mail.

When comparing actual enrollment to projected enrollment, the community engagement efforts boosted enrollment by 23% in the targeted rural clinics and 107% in the targeted low-enrollment clinics. There was no significant increase in enrollment in the untargeted group.

The strategies also successfully increased the enrollment of rural residents. Notably, 99% of rural residents who passed screening went on to enroll in the study, compared to only 32% of urban residents who passed screening—highlighting the rural participants’ high willingness to join the research once barriers were addressed.

“These findings contribute to a growing body of research demonstrating that pragmatic trials, when combined with strong community engagement, can help bridge healthcare disparities in rural populations,” the authors wrote.

Read the full report.

FM-TIPS is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases through the NIH HEAL Initiative. Learn more about FM-TIPS.

November 26, 2025: Goals-of-Care Conversations Affect Emergency Department Care in PRIM-ER Substudy

Headshots of Dr. Corita Gruzen and Dr. Keith Goldfeld
Dr. Corita Gruzen and Dr. Keith Goldfeld, principal investigators for PRIM-ER

In a single-site substudy of the PRIM-ER trial, an intervention to initiate palliative care in the emergency department did not increase the proportion of patients having goals-of-care conversations. However, when those conversations did occur, they frequently influenced patients’ care.

The article was published online ahead of print in Internal and Emergency Medicine.

PRIM-ER, an NIH Collaboratory Trial, was a stepped-wedge, cluster randomized trial of a palliative care training program in emergency departments in the United States. The program consisted of training in palliative care, simulation-based communication workshops, clinical decision support tools, and audit and feedback.

In the substudy led by Julia Murray of Ohio State University, which was conducted as a quality improvement initiative at a large academic medical center, the researchers wanted to explore whether the PRIM-ER intervention changed physician behavior at the institution. Although the proportion of critically ill patients having a goals-of-care conversation did not change, more than three-quarters of the patients who did have a conversation saw a change in code status, their care plan, hospice care, or updated advance care planning documents.

Read the full article.

PRIM-ER was supported within the NIH Pragmatic Trials Collaboratory by a grant award from the National Institute on Aging. Learn more about PRIM-ER.

November 20, 2025: NOHARM Explores Patients’ and Nurses’ Experiences With a Perioperative Nonpharmacologic Pain Care Education Program

Headshots of Dr. Andrea Cheville and Dr. Jon Tilburt
Dr. Andrea Cheville and Dr. Jon Tilburt, principal investigators for NOHARM

In 2 recent studies, as part of the NOHARM trial, researchers explored the perspectives of patients and nurses on the implementation of a perioperative nonpharmacologic pain care education program.

One study, published in JMIR Nursing, evaluated inpatient nurses’ perceptions of barriers and facilitators to implementing the Healing After Surgery initiative. Healing After Surgery is a program embedded in the electronic health record (EHR) that provides education and support to patients for incorporating nonpharmacologic pain care techniques into their individualized perioperative pain management plans.

The researchers found that the nurses understood the benefits of the program but had difficulty implementing unfamiliar pain care techniques and prioritizing the initiative due to other clinical demands. Read the full report.

In the second study, published in BMC Complementary Medicine and Therapies, the researchers used semistructured qualitative interviews to explore patients’ experiences participating in the Healing After Surgery initiative. Among other things, they found that patients generally liked the program and felt that it aligned with their beliefs about wellness techniques and concerns about opioids. Read the full article.

NOHARM, an NIH Collaboratory Trial, is a stepped-wedge, cluster randomized trial testing an EHR-embedded, bundled intervention comprised of patient- and clinician-facing decision support components that enable patients to integrate nonpharmacologic pain care into their perioperative management. The study is supported within the NIH Pragmatic Trials Collaboratory by a grant award administered by the National Institute on Aging through the NIH HEAL Initiative.

Learn more about NOHARM.

November 18, 2025: OPTIMUM Team Studies the Prevalence of Chronic Overlapping Pain Conditions

OPTIMUM logoPatients with chronic low back pain and other chronic overlapping pain conditions, compared with patients with low back pain alone, experienced more severe pain symptoms and higher levels of anxiety, depression, and fatigue, according to an analysis from the OPTIMUM trial.

The report was published in the October issue of the European Journal of Pain.

Chronic low back pain is one of 10 chronic overlapping pain conditions that are theorized to share the same underlying mechanism of pathophysiology. Little is known about the prevalence and co-occurrence of these conditions.

The other chronic overlapping pain conditions include migraine, chronic tension-type headache, fibromyalgia, irritable bowel syndrome, myalgic encephalomyelitis/chronic fatigue syndrome, temporomandibular disorders, urological chronic pelvic pain syndrome/painful bladder syndrome, endometriosis, and vulvodynia.

Among 285 participants in the OPTIMUM trial, 45% had one chronic overlapping pain condition and 24% had 2 or more of the conditions, in addition to chronic low back pain. The most common conditions were irritable bowel syndrome, myalgia encephalomyelitis/chronic fatigue syndrome, and fibromyalgia. Patients with overlapping pain conditions had worse scores on measures of physical functioning and pain symptoms.

“Given the financial, symptomatic, and frustrating burden of [chronic overlapping pain conditions], it is important that researchers explore these conditions in more detail and seek treatments which address symptoms that patients report as the most detrimental to everyday functioning,” the authors concluded.

Read the full article.

OPTIMUM, an NIH Collaboratory Trial led by Natalia Morone of Boston University and Boston Medical Center, is studying the addition of mindfulness-based stress reduction to usual care for patients with chronic low back pain, with the goal of improving pain outcomes and reducing opioid prescriptions. The study is supported within the NIH Pragmatic Trials Collaboratory through the NIH HEAL Initiative by a grant award administered by the National Center for Complementary and Integrative Health. Learn more about OPTIMUM.

October 29, 2025 Virtual Onboarding Meeting: CARNATION

NIH Pragmatic Trials Collaboratory Onboarding Meeting

October 29, 2025
Virtual

Purpose

Welcome and hear from our new NIH Collaboratory Trial; provide introductions and an overview of the NIH Pragmatic Trials Collaboratory; hear from the Core Working Groups; and engage in discussion.

Welcome and Opening Remarks
Lesley Curtis
Wendy Weber*

Overview of the NIH Pragmatic Trials Collaboratory
Lesley Curtis
Wendy Weber*

Working With the NIH Collaboratory Coordinating Center
Kevin Weinfurt

Get to Know the New UG3 NIH Collaboratory Trial 
Coordinated cARe paiN mAnagement Technology ImplementatiON (CARNATION)
Lynn DeBar
Rachel Gold
Nicole Cook

Introduction to the Core Working Groups

 

Closing Remarks
Kevin Weinfurt
Wendy Weber*

 

*Unable to attend the onboarding meeting due to the federal government shutdown.

October 28, 2025 Virtual Onboarding Meeting: EquiP PC

NIH Pragmatic Trials Collaboratory Onboarding Meeting

October 28, 2025
Virtual

Purpose

Welcome and hear from our new NIH Collaboratory Trial; provide introductions and an overview of the NIH Pragmatic Trials Collaboratory; hear from the Core Working Groups; and engage in discussion.

Welcome and Opening Remarks
Adrian Hernandez
Wendy Weber*

Overview of the NIH Pragmatic Trials Collaboratory
Adrian Hernandez
Wendy Weber*

Working With the NIH Collaboratory Coordinating Center
Adrian Hernandez

Get to Know the New UG3 NIH Collaboratory Trial 
Equitable Primary Care for Pain Care (EquiP PC)
Kari Stephens

Introduction to the Core Working Groups

 

Closing Remarks
Adrian Hernandez
Wendy Weber*

 

*Unable to attend the onboarding meeting due to the federal government shutdown.

November 10, 2025: NIH Pragmatic Trials Collaboratory Welcomes New Trials CARNATION and EquiP PC

We are excited to add 2 new NIH Collaboratory Trials to our portfolio of innovative pragmatic clinical trials embedded in healthcare systems.

CARNATION and EquiP PC are supported by the National Institute of Neurological Disorders and Stroke through the Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) program, a component of the Helping to End Addiction Long-Term Initiative℠, or NIH HEAL Initiative℠, to address the opioid crisis.

Headshots of Dr. Lynn DeBar, Dr. Rachel Gold, and Dr. Nicole Cook
Dr. Lynn DeBar, Dr. Rachel Gold, and Dr. Nicole Cook, principal investigators for CARNATION

CARNATION (Coordinated Care Pain Management Technology Implementation) will partner with a national network of community health centers to test a multicomponent implementation support intervention designed to enable community health centers’ systematic use of electronic health record technologies for coordinating primary care–based pain care that is congruent with integrative pain management. This type 3 hybrid effectiveness-implementation trial will generate urgently needed empirical evidence for how to make integrative pain management strategies available in community health centers, where limited resources present barriers to the delivery and coordination of such care.

Lynn DeBar, Rachel Gold, and Nicole Cook will serve as the co–principal investigators of the CARNATION trial. DeBar, who led the NIH Collaboratory Trials BackInAction and PPACT, is a distinguished investigator at the Kaiser Permanente Center for Health Research. Gold is a senior investigator and the program director of chronic disease, preventive health, and wellness at OCHIN. Cook is also a research investigator at OCHIN.

Headshots of Dr. Kari Stephens and Dr. Rodger Kessler
Dr. Kari Stephens and Dr. Rodger Kessler, principal investigators for EquiP PC

EquiP PC (Equitable Primary Care for Pain Care) will test the effectiveness of an adapted behavioral health integration toolkit to improve chronic pain care. The trial will assess outcomes such as reduced pain interference, improved integrated behavioral health, implementation success, and access to care with the goal of expanding access to high-quality, team-based chronic pain care in primary care settings.

The co–principal investigators of EquiP PC are Kari Stephens and Rodger Kessler. Stephens is a licensed clinical psychologist and a professor in family medicine at the University of Washington. Kessler is vice president for innovation at the DARTNet Institute.

These 2 new NIH Collaboratory Trials will extend the mission of the NIH Pragmatic Trials Collaboratory to strengthen the national capacity to implement cost-effective, large-scale research studies that engage healthcare delivery organizations as research partners. To date, the program has supported 36 NIH Collaboratory Trials covering a range of clinical areas and spanning a dozen NIH Institutes and Centers.

November 6, 2025: Enrollment Begins for APA-SM and iPATH Trials

Two of the newest NIH Collaboratory Trials have begun enrollment. Congratulations to the study teams from APA-SM and iPATH for reaching this important project milestone!

APA-SM Investigators

APA-SM is enrolling patients in a 4-week auricular point acupressure intervention for self-management of chronic pain in rural communities in South Carolina and Texas. The study will also include implementation outcomes, a cost-effectiveness analysis, and an evaluation of predictive factors for treatment response. The study is led by principal investigators Jennifer Kawi and Hulin Wu of UTHealth Houston and Jane Bolin of Texas A&M University.

APA-SM is supported within the NIH Pragmatic Trials Collaboratory by the National Center for Complementary and Integrative Health, with additional oversight from the National Institute of Neurological Disorders and Stroke. Learn more about APA-SM.

Headshot of Dr. Sara Singer

iPATH, led by principal investigator Sara Singer of Stanford University, is enrolling federally qualified health centers in California, Massachusetts, Ohio, and Puerto Rico in a stepped-wedge, cluster randomized, hybrid effectiveness-implementation trial of a practice transformation strategy for type 2 diabetes. The study will evaluate the impact of the practice transformation strategy and identify process elements that influence implementation effectiveness.

iPATH is supported within the NIH Pragmatic Trials Collaboratory by the National Institute on Minority Health and Health Disparities. Learn more about iPATH.

October 27, 2025: Study Snapshot and Updated Ethics Documentation Available for APA-SM Study

APA-SM Investigators
Dr. Jennifer Kawi, Dr. Jane Bolin, and Dr. Hulin Wu, principal investigators for APA-SM

A new study snapshot and updated ethics and regulatory documentation are now available for the APA-SM study. A year into the project, the research team reviewed and updated the minutes of their initial consultation with the Ethics and Regulatory Core.

New resources for APA-SM include:

APA-SM is testing a 4-week auricular point acupressure intervention for self-management of chronic pain in rural communities in South Carolina and Texas. The study will also include implementation outcomes, a cost-effectiveness analysis, and an evaluation of predictive factors for treatment response.

APA-SM is supported within the NIH Pragmatic Trials Collaboratory by the National Center for Complementary and Integrative Health, with additional oversight from the National Institute of Neurological Disorders and Stroke. Learn more about APA-SM.

October 9, 2025: New Living Textbook Chapter Explores Decentralized Elements of Pragmatic Clinical Trials

The NIH Pragmatic Trials Collaboratory this week published a new chapter of its Living Textbook of Pragmatic Clinical Trials. The chapter, Decentralized Pragmatic Clinical Trials, covers activities of a pragmatic trial that can occur remotely—at a location separate from an investigator’s location—such as participant engagement, recruitment, consent, study interventions and procedures, collection of patient-reported outcomes, and follow-up.

The chapter describes special considerations for decentralized trials, such as community health considerations and the vigilance needed to assure data quality, particularly as it relates to adherence with the study intervention, outcome ascertainment, and event monitoring.

The new chapter includes the following sections:

  1. What Is a Decentralized Trial?
  2. What Decentralized Elements Are Used in Pragmatic Trials?
  3. Community Health Considerations for Decentralized Approaches
  4. Quality Assurance

Most of NIH Collaboratory Trials have decentralized elements, as described in detail in Section 2.